Literature DB >> 11289747

Variations in diagnostic and therapeutic procedures in a multicentre, randomized clinical trial (EORTC 10853) investigating breast-conserving treatment for DCIS.

N Bijker1, E J Rutgers, J L Peterse, I S Fentiman, J P Julien, L Duchateau, J A van Dongen.   

Abstract

AIMS: To evaluate the diagnostic and therapeutic procedures which were followed in a European Organization for Research and Treatment of Cancer (EORTC) randomized clinical trial investigating the role of radiotherapy in breast-conserving treatment (BCT) for ductal carcinoma in situ (DCIS) of the breast.
METHODS: The medical files of 824 of the 1010 randomized patients (82%) were reviewed during site visits to 30 participating institutes.
RESULTS: Large variations occurred, particularly in the surgical procedures and histopathological work-up which were performed. Important risk factors like tumour size and margin status were poorly quantified in the medical files.
CONCLUSIONS: These findings emphasize the need for establishing uniform guidelines for diagnostic and therapeutic procedures for DCIS, and for clearly defined risk factors for recurrence after BCT for DCIS. Because of its randomized nature, the main question of the trial, i.e. the effect of radiotherapy on the risk of local recurrence, will not be influenced by variation. The risk of local recurrence in itself, and hence the success of BCT for DCIS, may however be influenced by the quality of the initial procedures that were conducted. Copyright Harcourt Publishers Limited.

Entities:  

Mesh:

Year:  2001        PMID: 11289747     DOI: 10.1053/ejso.2000.1062

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  4 in total

Review 1.  Is DCIS breast cancer, and how do I treat it?

Authors:  N Bijker; M Donker; J Wesseling; G J den Heeten; E J Th Rutgers
Journal:  Curr Treat Options Oncol       Date:  2013-03

2.  Low CD10 mRNA expression identifies high-risk ductal carcinoma in situ (DCIS).

Authors:  Jérôme Toussaint; Virginie Durbecq; Sevilay Altintas; Valérie Doriath; Ghizlane Rouas; Marianne Paesmans; Philippe Bedard; Benjamin Haibe-Kains; Wiebren A Tjalma; Denis Larsimont; Martine Piccart; Christos Sotiriou
Journal:  PLoS One       Date:  2010-08-10       Impact factor: 3.240

3.  Biological Markers Predictive of Invasive Recurrence in DCIS.

Authors:  Sharon Nofech-Mozes; Jacqueline Spayne; Eileen Rakovitch; Harriette J Kahn; Arun Seth; Jean-Phillippe Pignol; Lavina Lickley; Lawrence Paszat; Wedad Hanna
Journal:  Clin Med Oncol       Date:  2008-01-22

Review 4.  Ductal Carcinoma In Situ Biology, Biomarkers, and Diagnosis.

Authors:  Kylie L Gorringe; Stephen B Fox
Journal:  Front Oncol       Date:  2017-10-23       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.